DK3186638T3 - Serinproteaser som biomarkører for ovariecancer - Google Patents

Serinproteaser som biomarkører for ovariecancer Download PDF

Info

Publication number
DK3186638T3
DK3186638T3 DK15836342.4T DK15836342T DK3186638T3 DK 3186638 T3 DK3186638 T3 DK 3186638T3 DK 15836342 T DK15836342 T DK 15836342T DK 3186638 T3 DK3186638 T3 DK 3186638T3
Authority
DK
Denmark
Prior art keywords
biomarkers
ovarian cancer
serine proteases
proteases
serine
Prior art date
Application number
DK15836342.4T
Other languages
English (en)
Inventor
Andrew L Pecora
Original Assignee
Univ Hackensack Medical Center
Andrew L Pecora
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hackensack Medical Center, Andrew L Pecora filed Critical Univ Hackensack Medical Center
Application granted granted Critical
Publication of DK3186638T3 publication Critical patent/DK3186638T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK15836342.4T 2014-08-28 2015-08-28 Serinproteaser som biomarkører for ovariecancer DK3186638T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462043290P 2014-08-28 2014-08-28
PCT/US2015/047434 WO2016033464A1 (en) 2014-08-28 2015-08-28 Serine proteases as biomarkers for ovarian cancer

Publications (1)

Publication Number Publication Date
DK3186638T3 true DK3186638T3 (da) 2020-04-27

Family

ID=55400663

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15836342.4T DK3186638T3 (da) 2014-08-28 2015-08-28 Serinproteaser som biomarkører for ovariecancer

Country Status (6)

Country Link
US (1) US10662478B2 (da)
EP (1) EP3186638B1 (da)
CA (1) CA2960012C (da)
DK (1) DK3186638T3 (da)
ES (1) ES2786177T3 (da)
WO (1) WO2016033464A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2951514A1 (en) 2014-06-18 2015-12-23 Clear Gene, Inc. Methods, compositions, and devices for rapid analysis of biological markers
US11401558B2 (en) 2015-12-18 2022-08-02 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers
WO2018140049A1 (en) * 2017-01-30 2018-08-02 Mprobe Inc. Methods and compositions for detecting early stage ovarian cancer with rnaseq expression profiling
US10918327B2 (en) * 2017-02-02 2021-02-16 Coopersurgical, Inc. Compositions and methods for determining receptivity of an endometrium for embryonic implantation
IT202000011977A1 (it) * 2020-05-21 2021-11-21 Univ Degli Studi Di Bari Metodo per effettuare diagnosi molecolare in vitro di tumore ovarico e kit
CN111679073B (zh) * 2020-06-17 2021-10-19 南京市妇幼保健院 Klk13在制备诊断宫颈腺癌检测试剂盒上的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2448355A1 (en) * 2001-05-25 2002-12-05 Mount Sinai Hospital Method of detecting and monitoring prostate and ovarian cancers
AUPS161602A0 (en) * 2002-04-09 2002-05-16 Queensland University Of Technology Novel molecules and uses therefor
WO2004075713A2 (en) 2003-02-26 2004-09-10 Mount Sinai Hospital Multiple marker assay for detection of ovarian cancer
CN1922490B (zh) * 2004-02-19 2012-07-04 耶鲁大学 使用蛋白质组学技术鉴定癌症蛋白生物标志物的方法
WO2005098446A2 (en) * 2004-03-31 2005-10-20 The Johns Hopkins University Biomarkers for ovarian cancer
US7846446B2 (en) * 2006-11-22 2010-12-07 Board Of Trustees Of The University Of Arkansas Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer

Also Published As

Publication number Publication date
CA2960012A1 (en) 2016-03-03
EP3186638B1 (en) 2020-01-29
US10662478B2 (en) 2020-05-26
WO2016033464A1 (en) 2016-03-03
CA2960012C (en) 2021-06-22
US20160097102A1 (en) 2016-04-07
EP3186638A1 (en) 2017-07-05
ES2786177T3 (es) 2020-10-09
EP3186638A4 (en) 2018-03-21

Similar Documents

Publication Publication Date Title
DK3212780T3 (da) Serinprotease
DK3212662T3 (da) Serinproteaser
DK3212781T3 (da) Serinproteaser
DK3110970T3 (da) Biomarkører for endometriose
CL2014003041S1 (es) Carcasa para aoutoinyector.
DK3261639T3 (da) Substituerede pyrazolforbindelser som serinproteaseinhibitorer
DK3125898T3 (da) Farmakofor til trail-induktion
MA43957A (fr) Biomarqueurs de copanlisib
MA43958A (fr) Biomarqueurs copanlisib
DK3186638T3 (da) Serinproteaser som biomarkører for ovariecancer
DK3464789T3 (da) Brønddriftsværktøj
DK3198034T3 (da) Biomarkører for cervixcancer
GB201404189D0 (en) Novel biomarkers
GB201500729D0 (en) Novel Biomarkers
GB201517028D0 (en) Novel biomarkers for pancreatic cancer
MA43312A (fr) Sérine protéases recombinées
DK3373956T3 (da) Proenzymsammensætning
TH1601005994B (th) ตัวเรือนเครื่องมือประเภทคูหา
UA32421S (uk) Круг шліфувальний
TH1601003151A (th) คอมเพรสเซอร์
TH1601003145B (th) คอมเพรสเซอร์
TH1701002038B (th) คอมเพรสเซอร์
ES1140635Y (es) Abrasivo optimizado
TH1501007295B (th) คอมเพรสเซอร์แบบหมุน
TH1501007293B (th) คอมเพรสเซอร์แบบหมุน